Literature DB >> 15824475

Work, unemployment and life satisfaction among patients with diisocyanate induced asthma--a prospective study.

Päivi L Piirilä1, Helena M Keskinen, Ritva Luukkonen, Suvi-Päivikki Salo, Matti Tuppurainen, Henrik Nordman.   

Abstract

Occupational asthma has been found to be associated with lowered socio-economic outcomes, an increased unemployment rate and a decreased quality of life. The compensation of occupational diseases is comparatively favourable in Finland. Our aim was to follow-up the working status and life satisfaction of patients with diisocyanate-induced asthma in 245 cases diagnosed during 1976-1992. A questionnaire was sent out on average 10 (3-19) yr after the diagnosis to the surviving 235 patients. The questionnaire was validated by re-examining 91 of them clinically, and with spirometry, histamine challenge test and peak flow surveillance. Of the 213 responding patients, 14% were unemployed, and for 50% of them unemployment was caused by asthma. Unemployment was associated with nocturnal asthma symptoms (OR 10.93; CI 2.69-44.452), increased PEF variability (OR 8.46; CI 1.52-46.97) and with the use of short-acting beta-sympathomimetic medication (p=0.045). Satisfaction with life was associated with present working (OR 3.50; CI 1.73-7.06) and with good condition of asthma as assessed by the use of asthma medication (OR 0.49; CI 0.27-0.89) and objective measurements of the asthma condition, e.g. PEF variability (OR 0.21; CI 0.08-0.59). As a conclusion, unemployment was remarkably low as compared with earlier reports and related to the period of simultaneous economic recession. Unemployment, as well as dissatisfaction with life were associated with poor conditions of asthma. Unemployment was associated with improper asthma care favouring the use of short-acting beta-sympathomimetic medication. Proper follow-up of asthma is essential for minimizing the social complaints of occupational asthma, as well as for enhancing life satisfaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824475     DOI: 10.1539/joh.47.112

Source DB:  PubMed          Journal:  J Occup Health        ISSN: 1341-9145            Impact factor:   2.708


  8 in total

Review 1.  Diagnosis of occupational asthma: an update.

Authors:  Edgardo J Jares; Carlos E Baena-Cagnani; R Maximiliano Gómez
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

2.  New-onset adult asthma in relation to damp and moldy workplaces.

Authors:  Kirsi Karvala; Elina Toskala; Ritva Luukkonen; Sanna Lappalainen; Jukka Uitti; Henrik Nordman
Journal:  Int Arch Occup Environ Health       Date:  2010-02-03       Impact factor: 3.015

3.  Occupational diseases among call center operators needing vocal rehabilitation.

Authors:  Elif Altundaş Hatman; Sebahat Dilek Torun
Journal:  Med Lav       Date:  2022-06-28       Impact factor: 2.244

4.  Alterations in psychosocial health of people affected by asbestos poisoning.

Authors:  Miguel Clemente; Adela Reig-Botella; Juan Carlos Prados
Journal:  Rev Saude Publica       Date:  2015       Impact factor: 2.106

5.  Asthma-related health services and asthma control among women in Puerto Rico.

Authors:  María Calixta Ortiz-Rivera
Journal:  SAGE Open Med       Date:  2018-05-11

Review 6.  EAACI position paper on occupational rhinitis.

Authors:  Gianna Moscato; Olivier Vandenplas; Roy Gerth Van Wijk; Jean-Luc Malo; Luca Perfetti; Santiago Quirce; Jolanta Walusiak; Roberto Castano; Gianni Pala; Denyse Gautrin; Hans De Groot; Ilenia Folletti; Mona Rita Yacoub; Andrea Siracusa
Journal:  Respir Res       Date:  2009-03-03

7.  Diisocyanate-induced asthma in Switzerland: long-term course and patients' self-assessment after a 12-year follow-up.

Authors:  Martin Rüegger; Doreen Droste; Markus Hofmann; Marcel Jost; David Miedinger
Journal:  J Occup Med Toxicol       Date:  2014-05-14       Impact factor: 2.646

8.  Employment status changes of workers after referral to an occupational disease clinic.

Authors:  Ayse Coskun Beyan; Yucel Demiral; Arif Cimrin
Journal:  J Occup Health       Date:  2018-10-10       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.